Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and Criteria for Categorisation of Medicines

Documents

Red
Abatacept infusion and subcutaneous injection (Orencia®) in rheumatological conditions
Date Posted: 11 - Apr - 2018
Body System: Musculoskeletal system
Black
ACETYLCYSTEINE in idiopathic pulmonary fibrosis
Date Posted: 30 - Nov - 2018
Body System: Respiratory system
Red
ADALIMUMAB injection (Humira®) in rheumatological conditions
Date Posted: 11 - Apr - 2018
Body System: Musculoskeletal system
Red
ALIROCUMAB injection (Praluent®▼)
Date Posted: 07 - Jul - 2016
Body System: Cardiovascular system
Grey
ALIROCUMAB solution for injection (Praluent®▼) for reduction of cardiovascular risk in adults with established atherosclerotic cardiovascular disease
Date Posted: 26 - Apr - 2019
Body System: Cardiovascular system
Black
Antioxidant supplements for Age-Related Macular Degeneration
Date Posted: 07 - Jun - 2017
Body System: Eye
Black
ASCORBIC ACID
Date Posted: 25 - Jan - 2017
Body System: Blood and blood-forming organs
Amber retained
AZITHROMYCIN oral liquid and tablets – paediatric use
Date Posted: 23 - Oct - 2019
Body System: Anti-infective
Amber recommended
AZITHROMYCIN tablets for prevention of exacerbations of COPD and bronchiectasis in selected high-risk patients
Date Posted: 25 - Nov - 2015
Body System: Respiratory system